MapLight Therapeutics (MPLT) Current Leases (2024 - 2025)
MapLight Therapeutics' (MPLT) quarterly Current Leases came in at $891000.0 in Q4 2025, up 14.52% year-on-year from $778000.0 in Q4 2024, and up 3.36% quarter-over-quarter from $862000.0 in Q3 2025.
MapLight Therapeutics (MPLT) Current Leases (2024 - 2025) Analysis & Trends
MapLight Therapeutics has disclosed Current Leases across 2 years of filings, most recently posting $891000.0 for Q4 2025.
- Current Leases for Q4 2025 came in at $891000.0, up 14.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $891000.0 (up 14.52% YoY), and the FY2025 annual result was $891000.0, up 14.52% from the prior year.
- Current Leases came in at $891000.0 for Q4 2025 at MapLight Therapeutics, up from $862000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $891000.0 in Q4 2025 to a low of $778000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | MapLight Therapeutics | 248.88 Mn | 248.88 Mn | - | 891,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 891,000.00 |
| Sep 30, 2025 | 862,000.00 |
| Dec 31, 2024 | 778,000.00 |